The interleukin-23 axis in intestinal inflammation (original) (raw)

Evaluation of inflammatory activity in Crohn’s disease and ulcerative colitis

Maria de Lourdes Abreu Ferrari

World Journal of Gastroenterology, 2012

View PDFchevron_right

Combined blockade of the IL-13 and IL-33 pathways leads to a greater inhibition of Type-2 inflammation over inhibition of either pathway alone

Miriam Baca

Journal of Allergy and Clinical Immunology, 2017

View PDFchevron_right

Francisella tularensis Induces IL-23 Production in Human Monocytes

Murugesan Rajaram

Journal of Immunology, 2007

View PDFchevron_right

Inflammation

Oksana Sulaieva

Clinical Chemistry and Laboratory Medicine (CCLM), 2015

View PDFchevron_right

Inflammation at the interface of Innate and Acquired Immunity

Nebojsa Arsenijevic

Molecular Immunology, 2009

View PDFchevron_right

IL-33 Mediates Inflammatory Responses in Human Lung Tissue Cells

Kanami Orihara

The Journal of Immunology, 2010

View PDFchevron_right

Resequencing of positional candidates identifies low frequency IL23R coding variants protecting against inflammatory bowel disease

Colm O'Morain

Nature Genetics, 2011

View PDFchevron_right

Functional Relevance of the IL-23–IL-17 Axis in Lungs In Vivo

Ross Vlahos

American Journal of Respiratory Cell and Molecular Biology, 2007

View PDFchevron_right

Intestinal Epithelial Cells as a Source of Inflammatory Cytokines and Chemokines

Andrew Stadnyk

The Canadian journal of gastroenterology, 2002

View PDFchevron_right

Haemostatic system in inflammatory bowel diseases: New players in gut inflammation

Franco Scaldaferri

World Journal of Gastroenterology, 2011

View PDFchevron_right

IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut

Liliane Fossati-Jimack

Journal of Autoimmunity, 2014

View PDFchevron_right

IL-23 and IL-12 Have Overlapping, but Distinct, Effects on Murine Dendritic Cells

Roberta Bianchi

The Journal of Immunology, 2002

View PDFchevron_right

Biologic Therapies for Inflammatory Bowel Diseases

Vassilis Valatas

2013

View PDFchevron_right

Elevated Serum Level of IL-23 Correlates with Expression of VEGF in Human Colorectal Carcinoma

Nebojsa Arsenijevic

Archives of Medical Research, 2010

View PDFchevron_right

Factor XIII and inflammatory cells

László Muszbek

2012

View PDFchevron_right

Alarmin’ Immunologists: IL-33 as a Putative Target for Modulating T Cell-Dependent Responses

TANIA RASILLA CARRASCO

Frontiers in Immunology, 2015

View PDFchevron_right

Chronic inflammation and asthma

Jenna Macciochi

Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 2010

View PDFchevron_right

A Functional Role for Interleukin-21 in Promoting the Synthesis of the T-Cell Chemoattractant, MIP-3α, by Gut Epithelial Cells

Ilaria Peluso

Gastroenterology, 2007

View PDFchevron_right

Interactions Between the Microbiota and the Immune System

Andrew Macpherson

Science, 2012

View PDFchevron_right

Defensins and cytokines in inflammatory bowel disease

Arman Rahman

2007

View PDFchevron_right

Role of TNFSF15 in the intestinal inflammatory response

Tanya Kadiyska

World Journal of Gastrointestinal Pathophysiology, 2018

View PDFchevron_right

Proteomics and Metabolomics in Inflammatory Bowel Disease

Rupert Leong

Journal of Gastroenterology and Hepatology, 2013

View PDFchevron_right

Inflammatory Bowel Disease. From Bench to Bedside

Fergus Shanahan

Digestive and Liver Disease, 2004

View PDFchevron_right

The Value of Inflammatory Signals in Adaptive Immune Responses

Melanie Moses

Lecture Notes in Computer Science, 2011

View PDFchevron_right

Heterozygosity for IL23R p.Arg381Gln confers a protective effect not only against Crohn’s disease but also ulcerative colitis

Tamas Molnar

Alimentary Pharmacology & Therapeutics, 2007

View PDFchevron_right